Elsevier

Comprehensive Psychiatry

Volume 38, Issue 6, November–December 1997, Pages 305-314
Comprehensive Psychiatry

Folate and cobalamin in psychiatric illness

https://doi.org/10.1016/S0010-440X(97)90925-1Get rights and content

Abstract

The linkage of cobalamin and folate deficiency to psychiatric illness has been studied and debated since these vitamins were first discovered in the 1940s. The clinical relevance of these deficiencies remains the subject of investigation and scholarly discussion. This article reviews case reports and studies derived from a MEDLINE search for English-language articles related to folate, cobalamin, and psychiatric illness. Emphasis is given to clinical research and recent developments. Preclinical evidence for direct effects of folate and cobalamin on brain functioning is compelling, and numerous associations of their deficiencies to psychiatric illness are evident. These vitamin deficiencies may typically present initially with psychiatric symptoms, but any direct causal relationship to specific neuropsychiatric illnesses are not well defined. The relationship of these vitamins in dementia is significant, but they may only rarely be a cause of truly reversible dementia. Folate deficiency appears most tightly connected with depressive disorders, and cobalamin deficiency with psychosis. Contrary to intuition, vitamin deficiencies appear to occur infrequently with eating disorders. Other diagnoses have been investigated much less extensively. The diagnosis and management of these deficiencies in the context of neuropsychiatric illness is still a matter of discussion. The quality of clinical research in this area is improving, but there are many unanswered questions that affect clinical practice. Clinicians should remain vigilant to the possibility of deficiencies of folate and cobalamin in diverse psychiatric populations. Normal hematological indices do not rule out the deficiencies. Further study is needed to refine the detection and clinical management of these vitamin deficiencies in psychiatric populations.

References (57)

  • V.A Wesson et al.

    Change in folate status with antidepressant treatment

    Psychiatry Res

    (1994)
  • R Hunter et al.

    Toxicity of folic acid given in pharmacological doses to healthy volunteers

    Lancet

    (1970)
  • P.S.A Godfrey et al.

    Enhancement of recovery from psychiatric illness by methylfolate

    Lancet

    (1990)
  • T.E Parry

    Folate responsive neuropathy

    Presse Med

    (1994)
  • J Lindenbaum et al.

    Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

    N Engl J Med

    (1988)
  • S.N Young

    Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior

    Can J Physiol Pharmacol

    (1991)
  • D.L Evans et al.

    Organic psychosis without anemia or spinal cord symptoms in patients with vitamin B-12 deficiency

    Am J Psychiatry

    (1983)
  • T Bottiglieri et al.

    Folate deficiency, biopterin and monoamine metabolism in depression

    Psychol Med

    (1992)
  • T Bottiglieri et al.

    The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders

    Drugs

    (1994)
  • B.L Kagan et al.

    Oral Sadenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial

    Am J Psychiatry

    (1990)
  • D.M Hartley et al.

    Folate interactions with cerebral G proteins

    Neurochem Res

    (1990)
  • A Terreri et al.

    The biochemical basis of cobalamin deficiency

  • R.J Leeming et al.

    Tetrahydrofolate and hydroxycobalamin in the management of dihydropteridine reductase deficiency

    J Ment Defic Res

    (1982)
  • B.A Cooper et al.

    Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum

    N Engl J Med

    (1978)
  • J.F Kolhouse et al.

    Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin

    N Engl J Med

    (1978)
  • J Lindenbaum et al.

    Diagnosis of cobalamin deficiency. II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations

    Am J Hematol

    (1990)
  • Y Yao et al.

    Prevalence of vitamin B12 deficiency among geriatric outpatients

    J Fam Pract

    (1992)
  • R Crellin et al.

    Folates and psychiatric disorders: clinical potential

    Drugs

    (1993)
  • Cited by (147)

    • Neuropsychiatric manifestations in vitamin B12 deficiency

      2022, Vitamins and Hormones
      Citation Excerpt :

      B12 deficiency can manifest as psychosis alone or can present as depression with psychosis (Jayaram et al., 2013). B12 associated psychosis could manifest as suspiciousness, persecutory or religious delusions, auditory and visual hallucinations, tangential or incoherent speech, and disorganization in the thought process (Hutto, 1997). B12 deficiency can sometimes present with a fluctuating clinical picture characterized by affective changes, anxiety and restlessness, alteration in sensorium which could be collectively termed as atypical psychosis (Phillips & Kahaner, 1988).

    • Cobalamin Deficiency and Acute-Onset Auditory and Visual Hallucinations in an Elderly Man

      2021, Journal of the Academy of Consultation-Liaison Psychiatry
      Citation Excerpt :

      Methionine synthase (and thus, methylcobalamin) is also involved in the conversion of homocysteine to methionine (Figure 1A), which co-occurs with the aforementioned reaction.4–6 Methionine is important as it becomes S-adenosyl-methionine, the universal methyl donor essential for methylation reactions throughout the body (DNA, protein, phospholipids).4,6 S-adenosyl-methionine has also been shown to effect the rate of serotonin synthesis.6

    • Biometals in Autism Spectrum Disorders

      2020, Biometals in Autism Spectrum Disorders
    View all citing articles on Scopus
    View full text